Clinical Psychedelic Protocol Development

For psilocybin service centers, ketamine clinics, health systems & retreats

Pharmacist-designed screening criteria, medication policies and safety procedures, built for your setting, your regulations and your team, and implemented so they are actually used.

Most adverse events in psychedelic care are predictable

Serotonergic interactions, lithium, uncontrolled hypertension, seizure risk and abrupt antidepressant discontinuation are known, screenable risks. What is often missing is a written, evidence-based process that every facilitator and clinician follows the same way, every time. A protocol turns a pharmacist's judgment into your organization's standard of care.

Who I build protocols for

• Licensed psilocybin service centers: client screening, medication and health-condition guidance, and safety SOPs aligned with regulated programs such as Oregon's and Colorado's.

• Ketamine clinics and health systems: clinical criteria, monitoring standards and medication-interaction policies for ketamine and esketamine programs, and readiness planning for newly approved therapies.

• Retreats and facilitator teams: medical intake review, participant risk stratification and on-call pharmacist consultation for groups with complex medical or psychiatric needs.

How an engagement works

1. Discovery and gap assessment. A structured review of your setting, population, regulatory framework, staffing and existing documents, so we can see where medication risk is unmanaged today.

2. Screening and exclusion criteria. Evidence-based medical and psychiatric screening covering drug-drug and drug-disease interactions, cardiovascular and seizure risk, lithium, MAOIs, serotonergic load and when to refer.

3. Medication management policy. Clear guidance for participants who take psychiatric medications: what to coordinate with the prescriber, tapering-risk considerations, timing and documentation.

4. Session safety and emergency response. Monitoring standards, adverse-event recognition, escalation thresholds and emergency procedures matched to your setting and staff licensure.

5. Team training and implementation. Live training for facilitators, clinicians and staff, plus a follow-up review after launch so the protocol is used in practice, not just kept in a binder.

Ways to work together

• Protocol Review: an expert review of your existing intake, screening and medication policies, with a written redline and risk report.

• Full Protocol Build: all five steps above, from gap assessment through staff training.

• Pharmacist on Retainer: ongoing consultation for complex participants and protocol updates as the evidence changes.

Why work with me

I am a residency-trained clinical psychiatric pharmacist who has written coverage criteria for emerging neuropsychiatric therapies, including intranasal esketamine, for a health plan; built pharmacist-led clinical programs inside a community health center; and taught psychedelic pharmacology to clinicians since 2013. I train facilitator cohorts on interactions and screening, so my protocols are written in language both clinicians and facilitators can follow.

Satori Rx Consulting designs screening systems and advises your team; clinical decisions and medical clearance remain with appropriately licensed clinicians. Your legal counsel should confirm regulatory compliance in your jurisdiction.